Cognetivity Neurosciences’ AI Powered CognICA Platform Shortlisted for Major Industry Award
CognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX FestivalVancouver, British Columbia--(Newsfile Corp. - September 5, 2023)...
Brain
CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Live webcast presentation on Wednesday, September 13th at 10:30 AM ETHOUSTON, TX / ACCESSWIRE / September 5, 2023 / CNS...
Personalized Analysis From Breath Hub Redefines the Power of Breathwork
New research from the only app offering personalized breathwork analysis proves a science-based approach is the quickest way to help...
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement
Leading Louisiana and Mississippi Healthcare Provider Standardizes 10 Hospitals on Masimo SET® and Patient SafetyNet™ to Enhance Patient Safety and...
Cerevance Announces Presentation at the 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
BioVie to Host Virtual KOL Event on NE3107 in Alzheimer’s Disease on September 7, 2023
CARSON CITY, Nev., Aug. 31, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Healing the Wounds of Inflammatory Bowel Disease
A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a...
VitalPointTech Announces Acquisition of Herban Healing, LLC, a Revolutionary Bio-Pharmaceutical Company
Herban Healing is dedicated to providing alternative healthcare options to combat the opioid crisisHOUSTON, TX / ACCESSWIRE / August 29,...
Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer’s Disease
Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading Neuroscience Journal Demonstrates Unprecedented Sensitivity in...
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
Unmet Needs and Elevated Risk of Depression: The Challenges Faced by Caregivers of Noncancerous Brain Tumor SurvivorsOCEAN CITY, MD /...
Stress Affects Sex. Male Plus Can Help.
The Natural Libido Enhancer Includes Ginseng as a Way to Reduce Stress.Fort Lauderdale, FL, Aug. 30, 2023 (GLOBE NEWSWIRE) --...
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023
Additional biomarker data up to two years of treatment continue to demonstrate rapid and sustained normalization of CSF heparan sulfate...
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA...
Cognition Therapeutics Announces Participation in Upcoming September Conferences
PURCHASE, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative...
IRLAB publishes interim report for the period January-June 2023
GOTHENBURG, SE / ACCESSWIRE / August 30, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, August 30, 2023 - IRLAB Therapeutics...
Ocean Biomedical (NASDAQ: OCEA) Announces New Patent for Anti-Fibrosis Discovery with Allowance in Alcoholic Liver Disease and Multiple Fibrotic Conditions, Leading Causes of Death in the U.S.
Ocean’s small molecule candidate significantly controls fibrosis progression in idiopathic pulmonary fibrosis (IPF) and Hermansky-Pudlak Syndrome (HPS) in multiple testing...
Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
WAKEFIELD, MA, Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical...
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations...